List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 778 studies with search of: "Melanoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Interventions: Drug: dendritic cell-gp100-MART-1 antigen vaccine;   Drug: sargramostim
2 Active, not recruiting Phase II Trial of Allovectin-7® for Metastatic Melanoma
Conditions: Melanoma;   Metastatic Melanoma;   Malignant Melanoma;   Skin Cancer
Intervention: Genetic: Allovectin-7®
3 Completed Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Intervention: Drug: allovectin-7
4 Terminated A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma
Conditions: Melanoma;   Malignant Melanoma;   Metastatic Melanoma
Intervention: Drug: 131I-TM601
5 Completed Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Interventions: Drug: allovectin-7;   Drug: allovectin-7/dacarbazine;   Drug: dacarbazine
6 Completed Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Biological: recombinant interferon beta
7 Recruiting Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma
Conditions: Mucosal Melanoma;   Acral/Lentiginous Melanoma;   Chronically Sun Damaged Melanomas
Intervention: Drug: Imatinib
8 Recruiting Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
Conditions: Mucosal Melanoma;   Acral Melanoma;   Melanoma
Intervention: Drug: Nilotinib
9 Active, not recruiting Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Biological: incomplete Freund's adjuvant;   Biological: multi-epitope melanoma peptide vaccine;   Biological: sargramostim
10 Completed flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer
Conditions: Stage IV Melanoma;   Stage IV Renal Cell Cancer;   Recurrent Renal Cell Cancer;   Recurrent Melanoma
Interventions: Drug: flt3 ligand;   Drug: gp100 antigen;   Drug: MART-1 antigen;   Drug: Montanide ISA-51;   Drug: tyrosinase peptide
11 Active, not recruiting Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Biological: incomplete Freund's adjuvant;   Biological: multi-epitope melanoma peptide vaccine;   Biological: sargramostim
12 Recruiting Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
Conditions: Hereditary Melanoma 1 and 2 (cdkn2, cdk4);   Melanoma (Skin)
Interventions: Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Other: laboratory biomarker analysis;   Procedure: mutation carrier screening;   Procedure: study of high risk factors
13 Recruiting Comparison of Video-Based Versus Written Patient Education on Melanoma
Conditions: Melanoma;   Malignant Melanoma
Intervention: Other: Patient Educational Materials
14 Active, not recruiting Study of Temzolomide and Gleevec in Advanced Melanoma
Conditions: Melanoma;   Advanced Melanoma
Intervention: Drug: Gleevec + Temozolomide
15 Recruiting A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
Conditions: Skin Cancer;   Melanoma;   Metastatic Melanoma
Interventions: Drug: temozolomide;   Drug: ABT-888;   Drug: Placebo
16 Completed Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma;   Recurrent Melanoma
Interventions: Drug: gp100 antigen;   Drug: interleukin-2
17 Active, not recruiting Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: vorinostat
18 Active, not recruiting Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma;   Recurrent Melanoma
Interventions: Drug: allogeneic lymphocytes;   Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: fludarabine
19 Completed Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: ipilimumab
20 Active, not recruiting FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: romidepsin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services